These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1255 related articles for article (PubMed ID: 23302119)
101. Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening. Gray KJ; Wilkins-Haug LE Pediatr Radiol; 2018 Apr; 48(4):461-470. PubMed ID: 29550862 [TBL] [Abstract][Full Text] [Related]
102. Patient choice and clinical outcomes following positive noninvasive prenatal screening for aneuploidy with cell-free DNA (cfDNA). Dobson LJ; Reiff ES; Little SE; Wilkins-Haug L; Bromley B Prenat Diagn; 2016 May; 36(5):456-62. PubMed ID: 26938930 [TBL] [Abstract][Full Text] [Related]
103. Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy? Mennuti MT; Cherry AM; Morrissette JJ; Dugoff L Am J Obstet Gynecol; 2013 Nov; 209(5):415-9. PubMed ID: 23529082 [TBL] [Abstract][Full Text] [Related]
104. Factors affecting parental decisions to terminate pregnancy in the presence of chromosome abnormalities: a Japanese multicenter study. Nishiyama M; Sekizawa A; Ogawa K; Sawai H; Nakamura H; Samura O; Suzumori N; Nakayama S; Yamada T; Ogawa M; Katagiri Y; Murotsuki J; Okamoto Y; Namba A; Hamanoue H; Ogawa M; Miura K; Izumi S; Kamei Y; Sago H Prenat Diagn; 2016 Dec; 36(12):1121-1126. PubMed ID: 27760457 [TBL] [Abstract][Full Text] [Related]
105. [Prenatal diagnosis of trisomy 18 syndrome with sonogram index scoring system]. Peng R; Xie HN; Zhang Y; Luo YM; Li LJ; Zhu YX; Lin MF Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):845-9. PubMed ID: 22333235 [TBL] [Abstract][Full Text] [Related]
106. A Method to Quantify Cell-Free Fetal DNA Fraction in Maternal Plasma Using Next Generation Sequencing: Its Application in Non-Invasive Prenatal Chromosomal Aneuploidy Detection. Xu XP; Gan HY; Li FX; Tian Q; Zhang J; Liang RL; Li M; Yang XX; Wu YS PLoS One; 2016; 11(1):e0146997. PubMed ID: 26765738 [TBL] [Abstract][Full Text] [Related]
107. [Development of multiple quantitative fluorescent PCR for rapid diagnosis of common aneuploidy and it's clinical application]. Lu YP; Cheng J; Jiang SF; Zhang LW; Gao ZY; Han B; Yuan HJ; Li YL Yi Chuan; 2010 Nov; 32(11):1141-6. PubMed ID: 21513165 [TBL] [Abstract][Full Text] [Related]
108. [Value of nuchal translucency thickening in the fetal chromosome abnormality screening]. Sun LJ; Wang X; Wu QQ; Ruan Y; Yao L Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):819-23. PubMed ID: 24444557 [TBL] [Abstract][Full Text] [Related]
109. Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study. Khalil A; Archer R; Hutchinson V; Mousa HA; Johnstone ED; Cameron MJ; Cohen KE; Ioannou C; Kelly B; Reed K; Hulme R; Papageorghiou AT Am J Obstet Gynecol; 2021 Jul; 225(1):79.e1-79.e13. PubMed ID: 33460583 [TBL] [Abstract][Full Text] [Related]
110. [Performance of prenatal screening by non-invasive cell-free fetal DNA testing for women with various indications]. Zhang B; Pan L; Wang H; Liu J; Lu B; Chen Y; Long W; Yu B Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Feb; 35(1):51-55. PubMed ID: 29419860 [TBL] [Abstract][Full Text] [Related]
111. Prenatal diagnosis of mosaic trisomy 2 associated with abnormal maternal serum screening, oligohydramnios, intrauterine growth restriction, ventricular septal defect, preaxial polydactyly, and facial dysmorphism. Chen CP; Chen YY; Chern SR; Wu PS; Su JW; Chen YT; Lee CC; Chen LF; Wang W Taiwan J Obstet Gynecol; 2013 Sep; 52(3):395-400. PubMed ID: 24075380 [TBL] [Abstract][Full Text] [Related]
112. Effect of maternal age on foetal chromosomal defects: an investigation based on non-invasive prenatal testing. Li ZQ; Kang WL; Tang SJ; Mao Y; Fang T; Jiang JJ; Li XH J Obstet Gynaecol; 2023 Dec; 43(2):2287125. PubMed ID: 38069630 [TBL] [Abstract][Full Text] [Related]
113. Comparison of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women > or = 35 years old. Wenstrom KD; Desai R; Owen J; DuBard MB; Boots L Am J Obstet Gynecol; 1995 Oct; 173(4):1287-92. PubMed ID: 7485339 [TBL] [Abstract][Full Text] [Related]
116. The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort. Li SW; Barrett AN; Gole L; Tan WC; Biswas A; Tan HK; Choolani M Singapore Med J; 2015 Jan; 56(1):47-52. PubMed ID: 25640099 [TBL] [Abstract][Full Text] [Related]
118. Non-invasive prenatal testing for trisomy 21 based on analysis of cell-free fetal DNA circulating in the maternal plasma. Alberti A; Salomon LJ; Le Lorc'h M; Couloux A; Bussières L; Goupil S; Malan V; Pelletier E; Hyon C; Vialard F; Rozenberg P; Bouhanna P; Oury JF; Schmitz T; Romana S; Weissenbach J; Vekemans M; Ville Y Prenat Diagn; 2015 May; 35(5):471-6. PubMed ID: 25643828 [TBL] [Abstract][Full Text] [Related]
119. Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. Nicolaides KH; Syngelaki A; Gil M; Atanasova V; Markova D Prenat Diagn; 2013 Jun; 33(6):575-9. PubMed ID: 23613152 [TBL] [Abstract][Full Text] [Related]
120. Fetal aneuploidy screening with cell-free DNA in late gestation. Taneja PA; Prosen TL; de Feo E; Kruglyak KM; Halks-Miller M; Curnow KJ; Bhatt S J Matern Fetal Neonatal Med; 2017 Feb; 30(3):338-342. PubMed ID: 27124739 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]